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Abstract
Anopheles gambiae, the main mosquito vector of human malaria, is a challenging organism to manipulate
genetically. As a consequence, reverse genetics studies in this disease vector have been largely limited to RNA
interference experiments. Here, we report the targeted disruption of the immunity gene TEP1 using transgenic
expression of Transcription-Activator Like Effector Nucleases (TALENs), and the isolation of several TEP1 mutant A.
gambiae lines. These mutations inhibited protein production and rendered TEP1 mutants hypersusceptible to
Plasmodium berghei. The TALEN technology opens up new avenues for genetic analysis in this disease vector and
may offer novel biotechnology-based approaches for malaria control.
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Introduction
Malaria is caused by Plasmodium parasites transmitted to
their human hosts by the bite of anopheline mosquitoes.
Malaria has been charged with causing more human deaths
than any other disease in human history and continues to kill
about 660,000 annually [1]. A reduction in the malaria death toll
has been achieved thanks to vector control using insecticides
and insecticide-impregnated bednets, better health care and
progress in medical treatment, but this success is currently
mitigated by the spread of resistance both of mosquitoes to
insecticides and of Plasmodium to antimalarial drugs.
Sequencing the genome of the main malaria vector, Anopheles
gambiae [2], enabled the identification of hundreds of genes
involved in the vector’s capacity to transmit Plasmodium.
Altering the mosquito genome in a way that abates
Plasmodium transmission, through transgenesis or other
sophisticated genetic engineering tools, can offer new
perspectives in the fight against malaria. On one hand,
experimentally altering mosquito genes of interest will advance
our fundamental understanding of the biological interactions
between mosquito and parasite, and may help target
vulnerable points in the parasite cycle. On the other hand, the
prospect of releasing engineered male mosquitoes to
propagate malaria resistance genes through wild susceptible
vector populations has been receiving increasing attention
[3,4]. Novel methods to disrupt or alter target genes of interest
in the malaria mosquito would promote rapid progress towards
these goals. Furthermore, targeted genetic modifications that
do not require the permanent introduction of transposons in the
genome are particularly desirable, as they eliminate the
potential risk of subsequent unplanned transposon mobilization
by natural sources of transposition factors.
Recently, a novel class of DNA-binding protein domain
derived from the Xanthomonas Transcription Activator Like
Effector (TALE) proteins [5,6] has been successfully harnessed
to custom-design sequence-specific endonucleases [7,8].
These TALE nucleases (TALENs), in which the TAL DNA-
binding domain is fused to the FokI endonuclease domain, are
easy to engineer (e.g., [9,10]), highly predictable in their
sequence specificity, and highly mutagenic [11] making them
an attractive alternative to Zinc Finger Nucleases that have
less predictable binding specificities and require in vitro
optimization [12]. Mutations arise by imprecise repair of the
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TALEN-generated double-stranded breaks by the non-
homologous end joining (NHEJ) repair pathway. In a number of
animal species, injection of mRNA encoding TALENs have
readily allowed researchers to generate mutants in their genes
of interest [13–19]. Very recently, mutagenesis of an eye
pigmentation gene was achieved in Aedes mosquitoes using
this method [20]. In rice, disease resistant mutants have been
produced by transgenic expression of the TALENs, whose
respective transgenes were eliminated by subsequent genetic
crosses once the desired mutation had been fixed [21]. We
hypothesized that a similar approach would be applicable to
insect vectors and set out to use TALENs to target the TEP1
gene, a key component of the mosquito immune system.
Results
Since the embryo microinjection procedure is technically
challenging in Anopheles gambiae (as judged by poor survival
and relatively low success rate of transgenesis in this species),
we expected that mutant recovery after direct injection of
TALEN-encoding plasmids or mRNA might be difficult. For this
reason and to enable controlled mutagenesis experiments, we
preferred transgenic expression of the TALENs in the mosquito
germ cells. To obtain the proof-of-principle for gene targeting in
A. gambiae via transgenic TALENs, we selected the well-
characterized immune gene TEP1 as a target. TEP1, a protein
similar to vertebrate complement factor C3, binds Plasmodium
parasites as they invade the mosquito intestine and kills them
in a manner probably dependent on its thioester site located in
the C-terminus [22–25]. TEP1 mutants will be instrumental in
further dissecting the antiparasitic complement-like system in
mosquitoes.
TALENs function in pairs, each member of which binds a
chosen 12 to 24-nucleotide sequence. The two selected target
sequences are separated by 14-16 nucleotides, the optimal
distance for the two FokI domains of the TALENs to properly
dimerize and create a double-stranded break. Cleavage of the
bound DNA molecule occurs near the center of the sequence
separating the two target sites. We designed a single pair of
TALENs to target a site within the TEP1 gene centered on an
NcoI restriction site (5’-CCATGG-3’), offering the possibility to
easily screen individual mosquitoes for mutations that
destroyed the NcoI site (Figure 1A). Mutations in this region are
expected to strongly affect TEP1 protein function: frame-shifts
resulting in premature stop codons would remove the C-
terminal third of the protein including its thioester domain, while
amino-acid deletions or insertions would alter the length of the
alpha-helix connecting the CUB domain to the thioester domain
[26], presumably resulting in destabilization of the protein’s
structure.
A distinct transgenic mosquito line was generated for each
TALEN of the pair, the expression of which was driven by the
A. gambiae Vasa promoter, active in the mosquito germline
[27]. Therefore, F1 mosquitoes arising from a cross between
the two lines will express both TALENs simultaneously and are
expected to produce F2 gametes carrying mutations in the
TEP1 gene. To screen individual larvae within the F2 progeny,
we PCR-amplified a TEP1 fragment spanning the target site
and subjected the amplification product to a restriction digest
with NcoI (Figure 1B). Of 310 screened F2 larvae, 16 (5.16%)
carried a heterozygous mutation at the target locus, as
evidenced by the appearance of a PCR product that NcoI was
unable to cleave. Thus, at least 2.58% of TEP1 copies were
mutated after exposure to one TALEN dose (i.e., one
generation). This figure is a conservative estimate of mutation
frequency, as we subsequently observed some mutations that
left the NcoI recognition sequence intact. In order to obtain a
mosquito population containing a higher frequency of
mutations, we self-crossed successive generations of
mosquitoes expressing both TALENs of the pair. This was
facilitated by automated COPAS selection of larvae [28] that
had inherited one copy each of the left and right TALEN genes,
which are respectively associated with a red and yellow
fluorescent marker expressed in the nervous system [29]. At
least 1000 double-TALEN larvae were COPAS-selected and
cultured for each generation. In the 7th generation (i.e.,
exposure to 6 TALEN mutagenic doses), 51% (49 out of 96) of
the examined individual mosquitoes carried a heterozygous
mutation in TEP1. This indicated that the frequency of
mutations increased faster than predicted if mutations
accumulated linearly from one generation to the next. This
observation is consistent with a model where mosquitoes
already carrying a heterozygous mutation employ homologous
recombination to repair new TALEN-induced breaks in the wild-
type chromosome, thereby effectively copying the existing
mutation onto the newly damaged chromosome. This suggests
that in addition to NHEJ, TALEN-caused breaks can also be
repaired by homologous recombination. Therefore, the
observed number of NHEJ mutations is an underestimation of
the true rate of TALEN activity.
We wondered if a single TALEN of the pair is capable of
causing mutations in TEP1. To investigate this, we sampled
mosquito larvae from lines carrying a single TALEN maintained
at high population levels for 8 (right TALEN) or 10 (left TALEN)
generations, and again sampled larvae after about 16
generations. We expected that such a high number of
generations would have allowed rare “monotalenic” mutational
events to accumulate in the population. Out of 96 individual
larvae tested by PCR for each sample, none carried a mutation
in the TEP1 NcoI site. The observed absence of mutations
among 576 haploid genomes exposed to single TALEN activity
for 7, 9 or 15 generations suggests that single TALENs never
or rarely induce mutations at their target site. To strengthen this
point, we purified DNA from 2600 pooled larvae whose
genomes had been exposed to one TALEN of the pair for 7 or
9 generations, and PCR-amplified the target region. PCR
products appeared to be fully cleaved by NcoI, pointing to the
absence of TALEN-induced mutations. To increase the chance
of detection of a minor fraction of mutated products, we purified
the region of the gel in which uncleaved PCR products may
exist, cloned them into a plasmid, and examined E. coli
transformants containing single copies of the PCR products.
Again, all cloned fragments were cleaved by NcoI. Although we
note that deep sequencing of amplicons would provide a more
sensitive assay to detect rare mutations, this result further
suggests that single TALENs rarely or never generate mutants.
TALEN-induced TEP1 mutations in Anopheles gambiae
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Figure 1.  TALEN mutagenesis of the TEP1 gene.  A: Fragment from the TEP1 gene showing the target site of the TALEN pair.
Nucleotides bound by each TALEN are underlined, TALEN repeats are color-coded to show repeat/nucleotide specificity. The NcoI
restriction site centrally located at the TALEN cleavage site is highlighted. Inset: scheme of the entire TEP1 protein showing the
location of TALEN-induced mutations (SP: signal peptide; CUB: CUB domain interrupted by the TED: thioester domain; the star
indicates the position of the thioester site). B: PCR assay to identify TEP1 mutant mosquitoes. A PCR product spanning the TALEN
target site is generated from individual mosquitoes (small larva or a leg from a living adult) and incubated with NcoI. Full cleavage of
the PCR product (w) denotes a wild-type individual. Partial cleavage (h) denotes a heterozygous TEP1 mutant. Absence of
cleavage (H) corresponds to a homozygous TEP1 mutant. C: TALEN-induced mutations in the TEP1 gene. Left and right TALEN
target nucleotide sequences are shown in green and blue respectively, with the 15bp spacer sequence between the TALENs in
black. The NcoI restriction site is highlighted in orange. Deletions are designated by a red dash or by Δ+number of missing bases.
Insertions are shown in lowercase red letters. Uppercase red letters correspond to natural polymorphisms between multiple TEP1
alleles.
doi: 10.1371/journal.pone.0074511.g001
TALEN-induced TEP1 mutations in Anopheles gambiae
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The apparent absence of single TALEN background activity
was likely facilitated by our design scheme in which we used
obligate heterodimeric FokI domains in TALEN construction
[30,31].
The TALEN-generated TEP1 mutations were very similar in
nature to mutations obtained in other organisms (Figure 1C)
and consisted mainly of small deletions and insertions (indels)
that are the hallmark of imprecise NHEJ-mediated DNA repair.
Some mutations deleted a number of nucleotides in multiples
of three, resulting in the deletion of one to a few amino acids
from the TEP1 protein. Other mutations introduced a frame-
shift in the TEP1 coding sequence, resulting in the loss of the
entire C-terminal half of the protein, which contains features
crucial for TEP1 function including the thioester domain. Using
a PCR selection procedure from single legs taken from live
mosquitoes, we recovered five homozygous mutant mosquito
lines. These mutant lines were representative of the main
classes of mutations: line M∆T and M∆MV are deletions of 1
(Threonine) and 2 (Methionine and Valine) amino-acids,
respectively; line M∆3+6 lacks 3 endogenous amino-acids but
gained an insertion of 6 exogenous ones, line M∆ct1 and M∆ct2
are frame-shift mutations causing the loss of the entire protein
C-terminus (Figure 2A). Immunoblotting analysis failed to
detect TEP1 in the Mut∆ct1 and M∆ct2 lines, while it revealed
strongly reduced protein levels in M∆T, M∆MV and M∆3+6 lines
(Figure 2B, top). Although small amounts of TEP1 protein could
be detected in whole mosquito extracts of the M∆T, M∆MV and
M∆3+6 lines, these proteins did not undergo cleavage and were
impaired in their secretion to the hemolymph, as no TEP1
signal was observed in immunoblotting of hemolymph samples
(Figure 2B, bottom). Therefore, the alpha helix connecting the
CUB and thioester domains of TEP1 [26,32] seems to be very
sensitive to insertion or deletion of single amino acids that
destabilize the structure and prevent proper protein synthesis
and secretion.
We next assessed the phenotype of these mutant lines in
comparison to the parental lines by infection assays using
Plasmodium berghei-infected mice (Figure 3). Similar to the
RNA interference knockdown phenotype of TEP1 [22], all
mutations in the homozygous state resulted in a dramatic
increase in the number of developing parasites within the
mosquito gut. These results confirm the pivotal role of TEP1 in
antiparasitic responses. While it cannot be fully excluded that
RNAi-mediated TEP1 knockdown may also affect genes
sharing some nucleotide identity with the TEP1 sequence, such
as other closely-related genes in the TEP family [33], mutations
in TEP1 should leave the expression of other genes
unaffected.
Interestingly, while midguts from TEP1 mutant mosquitoes
often displayed impressive oocyst numbers that could exceed
1500, each experiment also yielded mutant midguts bearing no
or only a few oocysts. Upon blood feeding on a single infected
mouse, only well-gorged mosquito females were selected for
subsequent dissection. It is therefore unlikely that some
females ingested dramatically reduced numbers of P. berghei
gametocytes. Thus, it is apparent that TEP1-independent
mechanisms are at work to limit Plasmodium infection in a
subset of mosquitoes.
To examine the effect of TEP1 dosage in the process of
parasite killing, we compared oocyst infection levels between
TEP1 heterozygous mutant, homozygous mutant and control
mosquitoes (Figure 3d). The heterozygous mutant had an
intermediate susceptibility phenotype, which was closer to, but
significantly different from, the control. This suggests that the
efficiency of parasite killing depends on TEP1 protein levels.
The antiparasitic role of TEP1 was discovered and
characterized using RNA interference assays, in which
synthetically produced double-stranded RNA homologous to a
fragment of native TEP1 is injected at a high concentration in
the body of adult mosquitoes. This technique was generalized
for the functional characterization of hundreds of mosquito
genes [34]. However, injection per se was reported to impinge
on Plasmodium development by the potential induction of the
wounding response [35]. Therefore the mutant TEP1 lines
developed here will be useful in studies that must exclude the
confounding effect of the injection procedure itself. To examine
how the classical TEP1 RNAi phenotype compares with the
mutant phenotype, we compared parasite loads in M∆T to
dsTEP1-injected mosquitoes of the parental line (Figure 3e).
The mutant and RNAi phenotypes were very similar, validating
a posteriori the high efficiency of RNAi knockdown.
Discussion
Here, we obtained proof of principle that TALENs can be
used for targeted mutagenesis in the genome of the malaria
mosquito, which is notably difficult to manipulate genetically.
Recently, Aryan et al. [20] reported disruption of the eye
pigmentation kmo gene in the dengue vector mosquito Aedes
aegypti by injection of TALEN-encoding plasmid DNA. In the
same species, successful mutagenesis of GFP and of the
odorant receptor co-receptor (orco) was achieved by injecting
mRNA encoding Zinc Finger Nucleases [36]. In both cases and
in other animal systems for which TALEN mutagenesis has
been reported, mutants were obtained directly upon injection of
DNA or RNA into embryos. In contrast, we employed
transgenically-expressed TALENs for this purpose. Besides the
assurance of expressing the pair of TALENs in all germ cells,
this offered the possibility to increase the frequency of mutant
alleles in successive TALEN-expressing generations of
mosquitoes. We disrupted the antiparasitic gene TEP1 as a
first target; future work will make use of the obtained
hypersusceptible mutant lines to further dissect the role of this
important anti-malarial factor in parasite killing. Beyond the
research field of mosquito immunity, this study paves the way
for numerous other applications such as obtaining mutations in
Anopheles genes considered to be essential for Plasmodium
parasite development [37–39]. Disrupting these genes, or
altering specific domains on the encoded proteins, may render
homozygous mutant mosquitoes unable to support parasite
development. Such parasite-refractory mutant mosquitoes
could be used in anti-malaria intervention schemes, including
vector population replacement in endemic regions. Unless a
gene-drive strategy is specifically designed to spread desired
mutations, this could be achieved by the repeated release of
mass-produced male mosquitoes. Where knockout mutants in
TALEN-induced TEP1 mutations in Anopheles gambiae
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a given target gene might compromise the fitness of the
mosquitoes, TALEN mutagenesis offers the possibility of a
gene therapy to cure mosquitoes of malaria by selecting
mutations that prevent a protein’s interactions with parasite
factors while preserving its other vital functions. TALEN
mutagenesis could also be employed to knock out male fertility
genes for use in the Sterile Insect Technique to reduce vector
populations [40]. Of note, the TALEN transgenes used to
obtain a desired mutation can subsequently be discarded by
selection, thereby rendering the obtained homozygous mutant
mosquitoes transgene-free. This could facilitate mosquito
Figure 2.  TEP1 mutant proteins.  A: Fragment of the TEP1 protein encompassing the TALEN-induced mutations is shown for the
wild-type (WT) and for those mutants that we maintain as homozygous mosquito lines (M∆T, M∆MV, M∆3+6, M∆ct1 and M∆ct2). Gaps in the
protein sequence denote amino acid deletions. Inserted exogenous amino acids are shown in red. Nonsense amino acids followed
by a stop codon (*), resulting from frame-shift mutations, are shown in blue. B: Immunoblots to evaluate the presence of mutant
TEP1 protein in whole mosquito extract (top panels) or hemolymph. Hemolymph prophenoloxidase (PPO) serves as a loading
control. In the control samples, both TEP1 full-length (full) and C-terminal fragment (cleaved) are visible. Cross-reacting background
bands, some running in close proximity to TEP1 fragments, are marked on the left with ‘>’ signs.
doi: 10.1371/journal.pone.0074511.g002
TALEN-induced TEP1 mutations in Anopheles gambiae
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Figure 3.  TEP1 mutant mosquitoes are hypersusceptible to P. berghei.  Mosquito females from five different homozygous
mutant mosquito lines and from control parental lines were offered a blood meal on a P. berghei-infected mouse. Seven days after
infection, the midgut was dissected and the number of oocysts developing in each midgut was evaluated. The statistical significance
of differences in mean parasite numbers was measured with a Mann-Whitney test (mutant versus control) and with a Kruskall-Wallis
test followed by Dunn’s post-test (to compare all groups in [d]). (a) M∆T mosquitoes are compared to the two parental, non-mutant
TALEN lines. (b) 4 different mutant lines are compared to the parental mosquito line that initially served to produce TALEN
transgenic lines. This control line was verified to show the same level of susceptibility to P. berghei as the two TALEN daughter lines
(not shown). In this experiment, three mutant lines showed significantly elevated parasite numbers compared to the control while the
M∆ct2 line did not, presumably due to a different physiological condition of this mosquito culture. In two independent experiments (c,
d), we used mosquitoes of different genotypes marked with distinct fluorescence markers and cultured the larvae together in the
same water to eliminate potential confounding factors due to rearing conditions. On the day of dissection, genotypes were
separated on the basis of fluorescence. The same M∆ct2 line shows significantly elevated parasite numbers. (d) Heterozygous M∆ct2
mosquitoes are compared to control and homozygous M∆ct2 mosquitoes: the susceptibility phenotype of the heterozygote is
intermediate. (e) Control mosquitoes of the parental line, mosquitoes of the parental line injected with TEP1 double-stranded RNA,
and homozygous TEP1 mutant mosquitoes of the M∆T line are compared. TEP1 mutant and dsRNA-injected mosquitoes show
comparable susceptibility to P. berghei.
doi: 10.1371/journal.pone.0074511.g003
TALEN-induced TEP1 mutations in Anopheles gambiae
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Our experimental protocols were approved by Comité de
Qualification Institutionnel (CQI), the ethics evaluation
committee of INSERM (IRB00003888, FWA00005831).
Mosquitoes were reared and blood-fed on anesthetized mice in
compliance with French and European laws on animal house
procedures (agreement E67-482-2 of the Direction of
Veterinary services of the French Ministry of Agriculture).
Assembling the TALENs
TALENs targeting the sites shown in Figure 1 were
constructed by Golden Gate Cloning according to [9]. For
TALEN assembly, we prepared two transgenesis-compatible
destination vectors (annotated sequences provided in Text S1)
encoding a Venus yellow fluorescent and a DsRed fluorescent
transgenesis reporter gene, respectively. These vectors also
contain a phage ϕC31 attB site for genomic integration into
transgenic lines harboring attP sites. The first module used in
Golden Gate assembly provided the Vasa promoter
characterized in [27]. The last module closed the TALEN
assembly with either a FokI-DD or a FokI-RR domain [30],
designed for obligate heterodimerization of the two TALENs
and codon-optimized for A. gambiae. The annotated sequence
of the three plasmids is provided in Text S1. The TALEN C and
N-terminal domains flanking the repeat region were identical to
those used in [7].
A. gambiae lines and mosquito transgenesis
The TALEN-encoding vectors were inserted by ϕC31
integrase-mediated transgenesis [41] into the genome of A.
gambiae lines X1 and X13, which are derived from laboratory
strain G3. These two lines carry a PiggyBac transgene on
chromosome II, containing an attP docking site. Individual
transgenic larvae carrying the inserted left or right TALEN
genes at the X1 or X13 attP site were identified by their red or
yellow fluorescence, respectively. Resulting adults were
crossed to their non-fluorescent parental line. In the F2
generation, fluorescent homozygous larvae were COPAS-
selected [28] to establish stable TALEN-expressing lines.
Identification of TEP1 Mutants
In putative mutants (mosquitoes arising from parents
expressing both TALENs), we PCR amplified a region of TEP1
spanning the TALEN target site using Phusion or Phire
Polymerases (Thermo, Fisher) and primer 5’-
TCAACTTGGACATCAACAAGAAGGCCGA-3’ in combination
with either 5’-GCATATCTTTGTGCCACACTTT-3’ or 5’-
GCCACCGTAACGAATTTCCA-3’. The PCR product was
digested with NcoI (Fermentas), the recognition site of which is
centrally located in the sequence cut by the TALENs. PCR
products corresponding to mutant TEP1 alleles were not
digested by NcoI. These PCR products were sequenced
directly in the case of homozygous individuals, or cloned
(CloneJET PCR Cloning Kit, Fermentas) and subsequently
sequenced.
Mutagenesis and mutant line recovery
For mutagenesis experiments, the two TALEN lines were
crossed. From the F2 generation onwards, 1000 mosquito
larvae that inherited a single copy of each TALEN were
COPAS-purified to initiate the next generation. To isolate TEP1
mutants, mosquitoes from this population were out-crossed to
the parental line. The progeny carried a single TALEN and was
therefore no longer subjected to TALEN mutagenesis. Among
this progeny, we screened single adult mosquitoes by PCR on
one leg using the Phire direct animal tissue PCR kit (Thermo,
Fisher). The identified heterozygous mutants were individually
crossed to the parental line. In the F2 progeny, we identified
homozygous mutants by leg PCR and pooled them to start
distinct homozygous mutant families.
RNAi and infection assays
RNAi silencing of TEP1 by double-stranded RNA injection
into the thorax of adult mosquitoes and mosquito infections on
mice carrying Plasmodium berghei GFP-con 259cl2 were
performed as described [22]. To semi-automatically quantify
the number of oocysts in photographs of dissected mosquito
midguts, we used the “watershed segmentation” and “analyze
particles” plugins of the ImageJ software after digital
subtraction of the image background and smoothing of the
signal. Oocyst counts obtained by this method are consistent
with those obtained by manual counting of oocysts.
Immunoblotting
Whole-body mosquito extracts were obtained by grinding
one adult female mosquito in 80 µl of protein sample buffer.
The sample was denatured for 3 min at 95°C and centrifuged.
8 µl were loaded on 8% SDS-polyacrylamide gels. Hemolymph
samples were prepared as described [42], 10 µl of the samples
were loaded. Immunoblotting was performed using standard
procedures [43] with rabbit polyclonal antibodies raised against
the prophenoloxidase PPO2 [44] or against the C-terminal half
of TEP1 [45].
Supporting Information
Text S1.  The nucleotide sequences of plasmids and
building blocks used to construct the TALEN-expressing
transgenesis vectors are provided. Building blocks not listed
here are published in references 5,7.
(DOCX)
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